RETINOIC ACID EARLY TRANSCRIPT 1E
UNII S25MW4HRD6

Substance Identification & Data

This profile provides standardized clinical and technical data for Retinoic Acid Early Transcript 1e, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S25MW4HRD6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
S25MW4HRD6
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RETINOIC ACID EARLY TRANSCRIPT 1E
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retinoic Acid Early Transcript 1e. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LYMPHOCYTE EFFECTOR TOXICITY ACTIVATION LIGAND
N2DL-4
NKG2D LIGAND 4
NKG2DL4
RAE-1-LIKE TRANSCRIPT 4
RETINOIC ACID EARLY TRANSCRIPT 1E
UL16-BINDING PROTEIN 4